Taiwan's bio-industry has been developed for more than 30 years and has grown to maturity gradually. “The successors of Taiwan's bio-industry” forum, held by Department of Economic Development Taipei City Government on July 19, invited senior entrepreneurs and young generation to present their viewpoints and discuss the future of Taiwan's bio-industry.

Organizer :
Dr. Jo Shen , Co-founder of ScinoPharm Taiwan Ltd.
Panelists:
George Yeh, President of Taiwan Liposome Company
Yan-shih Shen, Chairman of Apex Biotechnology Corp.
Wen-ying Huang, President of Lumosa Therapeutics Co Ltd.
Allen Lin, CEO of Apollo Medical Optics Inc

Sharing of essential of entrepreneurship

Sharing experience of entrepreneurship from four panelists:

Deputy Director of Industrial Development Bureau Wu delivered a speech

President Huang shared industrial experience.

President Yeh suggested that fundraising is important for startups and should be carefully managed.

CEO Lin suggested that entrepreneurship aim at setting up platforms

Sealing the gap of technology transfer

Chairman Shen said, enterprises regard foundations as their own lab and they are reluctant to invest in R&D personnel training, so that technology transfer become a gap between industry and academia and make domestic doctors hard to find jobs.

Establishment of complete bio-industrial chain

President Huang suggested that accessories bio-industry is not well-developed and it should be strength.

Sharing experience of pharmaceutical industry in Silicon Valley